Seer (SEER) Gross Margin (2020 - 2026)

Seer (SEER) recorded quarterly Gross Margin of 35.16% in Q1 2026, down 32.34% quarter-over-quarter from 51.96% in Q4 2025, and down 1385.0% on a YoY basis from 2.74% in Q1 2025.

Seer (SEER) Gross Margin (2020 - 2026) Analysis & Trends

Seer's Gross Margin history runs 7 years deep, the most recent figure standing at 35.16% for Q1 2026.

  • In Q1 2026, Gross Margin fell 1385.0% year-over-year to 35.16%; the TTM figure through Mar 2026 stood at 48.7% (down 196.0% YoY), while the FY2025 annual figure was 51.06%, up 127.0% from the prior year.
  • Gross Margin was 35.16% for Q1 2026 at Seer, down from 51.96% in the prior quarter.
  • In the past five years, Gross Margin ranged from a high of 56.91% in Q2 2023 to a low of 35.16% in Q1 2026.
  • Historically, Gross Margin has averaged 48.51% across 5 years, with a median of 49.84% in 2022.
  • The sharpest annual moves came in 2022 and 2023: Gross Margin slumped 6244 bps in 2022, then surged 1346 bps in 2023.
  • A 5-year view of Gross Margin shows it stood at 49.84% in 2022, then dropped by 10 bps to 45.09% in 2023, then climbed by 12 bps to 50.62% in 2024, then rose by 3 bps to 51.96% in 2025, then slumped by 32 bps to 35.16% in 2026.
  • The last three Gross Margin figures came in at 35.16% (Q1 2026), 51.96% (Q4 2025), and 51.2% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Alterity Therapeutics 719,706.53 Bn 719,706.50 Bn - -
2 Belite Bio 55,800.00 Bn 55,800.00 Bn - -
3 Quantum Biopharma 18,182.30 Bn 18,182.29 Bn - -
4 Legend Biotech 3,154.00 Bn 3,153.71 Bn 242.10 Mn 79.04%
5 Akari Therapeutics 1,844.30 Bn 1,844.29 Bn - -
6 Evaxion A 1,567.96 Bn 1,567.94 Bn - -
7 Psyence Biomedical 251.43 Bn 251.42 Bn - -
8 Vertex Pharmaceuticals 112.56 Bn 105.31 Bn 2.59 Bn 86.85%
9 Abivax 94.37 Bn 94.37 Bn - -
10 Seer 99.67 Mn 99.67 Mn 982,000.00 35.16%

Historic Data

Download Data
DateValue
Mar 31, 2026 35.16%
Dec 31, 2025 51.96%
Sep 30, 2025 51.20%
Jun 30, 2025 52.11%
Mar 31, 2025 49.01%
Dec 31, 2024 50.63%
Sep 30, 2024 48.07%
Jun 30, 2024 56.35%
Mar 31, 2024 44.39%
Dec 31, 2023 45.09%
Sep 30, 2023 51.80%
Jun 30, 2023 56.91%
Mar 31, 2023 51.02%
Dec 31, 2022 49.84%
Sep 30, 2022 49.18%
Jun 30, 2022 44.44%
Mar 31, 2022 37.56%
Dec 31, 2021 46.74%
Sep 30, 2021 54.25%
Jun 30, 2021 56.07%